The FDA has approved rivaroxaban to reduce the risk of major cardiovascular events including stroke, myocardial infarction and cardiovascular death for people with chronic peripheral or coronary artery disease (PAD/CAD).

Antiepileptic drugs, regardless of brand or type, increase risk of stroke in seniors diagnosed with Alzheimer’s disease, according to research published in the Journal of the American Heart Association.

Direct oral anticoagulants (DOACs) can cut the short-term risk of thromboembolic events in half for patients who have undergone cardioversion of atrial fibrillation (AFib), suggests a meta-analysis published in the Journal of the American College of Cardiology.

When cardiologists get involved in the treatment of patients with a history of cancer and newly diagnosed atrial fibrillation (AFib), those people see a subsequent 11 percent reduction in the risk of stroke, according to a new study in the Journal of the American College of Cardiology. But those visits occur less often for that subgroup of patients than in AFib patients without cancer.

Patients who experience ischemic stroke in the posterior circulation are at greater risk of impaired functional outcomes compared to those with anterior circulation stroke (ACS)—particularly if their time to hospital arrival exceeds 4.5 hours, according to an Austrian registry study published Oct. 8 in Stroke.

Half of women and a third of men will be diagnosed with stroke, dementia or parkinsonism in their lifetime, according to a nearly three-decades-long study of neurological disease in the Dutch population. Up to 50 percent of those cases, though, might be mitigated with early prevention.

About 72 percent of active smokers with peripheral artery disease (PAD) continued to smoke a year after visiting a specialty vascular clinic for new or worsening claudication, according to a new study, despite more than three-quarters of them being offered advice or support to quit.

Patients with peripheral artery disease (PAD) and a history of lower extremity revascularization (LER) face an increased risk of both cardiac and limb ischemic events and subsequent revascularization, according to research published in the Journal of the American College of Cardiology Oct. 2.